This course approaches health law both from an institutional and from an ethical perspective. This first offers a policy approach towards public healthcare. Many developed countries have (partially) publicly funded healthcare systems. However, mainly due to the increasingly expensive treatments, increased life expectancy and the economic crisis, public healthcare systems are under pressure. This course analyses the new equilibrium that has to be found between public and private funding. The application of Market principles will be approached through party autonomy. The second perspective starts from (the limitations of) private autonomy vis-à-vis the seemingly unlimited possibilities of (bio) technology. Biomedicine and new technologies such as genetics, cloning and stem cell-therapy pose ethical questions. Personal autonomy has to be recognised but cannot be given free reign. These concerns are giving rise to long and difficult debates on the European and the international level, due to the important cultural, social, ethical and religious differences between the member states. As such the course offers students an insight in the close relationship between the ethical and legal aspect of health law and encourages them to share their arguments and opinions in class.